We are live on ! Find out more
MAM

Meeder Asset Management Portfolio holdings

AUM $1.75B
1-Year Est. Return 34.85%
This Fund
S&P 500
This Quarter Est. Return
-0.02%
1 Year Est. Return
+34.85%
3 Year Est. Return
+121.24%
5 Year Est. Return
+152.15%
10 Year Est. Return
+544.68%
AUM
$1.08B
AUM Growth
-$99.6M
Cap. Flow
-$85.6M
Cap. Flow %
-7.95%
Top 10 Hldgs %
22.85%
Holding
1,895
New
210
Increased
564
Reduced
645
Closed
335

Sector Composition

Rank Sector Weight
1 Financials 15.39%
2 Technology 13.91%
3 Healthcare 10.79%
4 Consumer Discretionary 8.13%
5 Industrials 7.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GPI icon
1376
Group 1 Automotive
GPI
$3.23B
$2K ﹤0.01%
35
-27
-44% -$2K
KAI icon
1377
Kadant
KAI
$3.95B
$2K ﹤0.01%
26
-1,627
-98% -$160K
KODK icon
1378
Kodak
KODK
$925M
$2K ﹤0.01%
424
-1,294
-75% -$8.31K
LFVN icon
1379
LifeVantage
LFVN
$83M
$2K ﹤0.01%
600
MGNX icon
1380
MacroGenics
MGNX
$255M
$2K ﹤0.01%
+67
New +$1.63K
NSIT icon
1381
Insight Enterprises
NSIT
$4.51B
$2K ﹤0.01%
43
-310
-88% -$11.2K
NTLA icon
1382
Intellia Therapeutics
NTLA
$1.57B
$2K ﹤0.01%
77
-218
-74% -$5.36K
NVAX icon
1383
Novavax
NVAX
$1.27B
$2K ﹤0.01%
53
+13
+33% +$522
OFLX icon
1384
Omega Flex
OFLX
$312M
$2K ﹤0.01%
24
OVBC icon
1385
Ohio Valley Banc Corp
OVBC
$206M
$2K ﹤0.01%
41
OVID icon
1386
Ovid Therapeutics
OVID
$495M
$2K ﹤0.01%
291
+203
+231% +$1.64K
PHX
1387
DELISTED
PHX Minerals
PHX
$2K ﹤0.01%
108
-432
-80% -$8.54K
PTGX icon
1388
Protagonist Therapeutics
PTGX
$9.4B
$2K ﹤0.01%
343
-58
-14% -$1.09K
RH icon
1389
RH
RH
$3.56B
$2K ﹤0.01%
24
-25,628
-100% -$2.27M
RIGL icon
1390
Rigel Pharmaceuticals
RIGL
$733M
$2K ﹤0.01%
55
-54
-50% -$2.16K
DCOY
1391
Decoy Therapeutics
DCOY
$2.16M
0
SNDX icon
1392
Syndax Pharmaceuticals
SNDX
$1.76B
$2K ﹤0.01%
+145
New +$1.54K
SPNT icon
1393
SiriusPoint
SPNT
$2.75B
$2K ﹤0.01%
148
-3,551
-96% -$50.4K
SPSC icon
1394
SPS Commerce
SPSC
$2.59B
$2K ﹤0.01%
62
-38
-38% -$1.07K
SPTN
1395
DELISTED
SpartanNash
SPTN
$2K ﹤0.01%
101
STAA icon
1396
STAAR Surgical
STAA
$1.15B
$2K ﹤0.01%
112
TOVX icon
1397
Theriva Biologics
TOVX
$10.3M
$2K ﹤0.01%
1
VTOL icon
1398
Bristow Group
VTOL
$1.33B
$2K ﹤0.01%
105
-61
-37% -$1.23K
RPT
1399
Rithm Property Trust
RPT
$94.2M
$2K ﹤0.01%
25
-113
-82% -$8.77K
PAMT
1400
PAMT Corp
PAMT
$315M
$2K ﹤0.01%
248
-104
-30% -$945

Similar funds

Meeder Asset Management's Q1 2018 Portfolio in Review

As of Q1 2018, Meeder Asset Management held 1,895 positions worth $1.08B, down 8.5% from $1.18B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Meeder Asset Management withdrew a net $85.6M in Q1 2018, closing 335 positions and reducing 645 holdings. Its most notable exit was Prologis, an estimated $4.69M position sold in full.

By sector, the portfolio is most concentrated in Financials at 15% of assets, up from 13% a quarter earlier, followed by Technology and Healthcare.

Against the trend, Meeder Asset Management opened a new position in Vanguard Intermediate-Term Corporate Bond ETF worth $30M.

  • Meeder Asset Management's largest Q1 2018 buy was Vanguard Intermediate-Term Corporate Bond ETF: 354,159 shares worth $30M.
  • Meeder Asset Management added most to Vanguard Total Bond Market in Q1 2018, an estimated $11.6M increase.
  • Meeder Asset Management's biggest Q1 2018 reduction was iShares 7-10 Year Treasury Bond ETF, cutting an estimated $51.6M.
  • Meeder Asset Management fully exited Prologis in Q1 2018, selling an estimated $4.69M.
  • Meeder Asset Management's ten largest holdings make up 23% of its $1.08B portfolio in Q1 2018.
  • Meeder Asset Management opened 210 new positions and closed 335 in Q1 2018.
  • Meeder Asset Management's portfolio value fell 8.5% quarter-over-quarter to $1.08B.

Based on Meeder Asset Management's 13F filing for Q1 2018, filed 3 May 2018.